Distribution of carbon-14 labeled C60 ([14C] C60) in the pregnant and in the lactating dam and the effect of C60 exposure on the biochemical profile of urine

Journal of Applied Toxicology

Volumn 30, Issue 4, 2010, Pages 354-360

  Sumner, Susan C J ^a   Fennell, Timothy R ^a   Snyder, Rodney W ^a   Taylor, George F ^a   Lewin, Anita H ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

14C C60; Disposition; Fetuses; Fullerene; Lactating dam; Metabolomics; Offspring; Pregnant dam

Indexed keywords

CARBON 14; FULLERENE DERIVATIVE; PURINE; PYRIMIDINE; SULFUR AMINO ACID;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CITRIC ACID CYCLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FECES LEVEL; FEMALE; FETUS; GASTROINTESTINAL TRACT; GENITAL SYSTEM; GLYCOLYSIS; HEART; LACTATION; LIVER; LUNG; METABOLITE; METABOLOMICS; MILK LEVEL; NONHUMAN; PLACENTAL TRANSFER; PLASMA; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SPLEEN; TISSUE DISTRIBUTION; UREA CYCLE; URINE LEVEL;

ANIMALS; ANIMALS, NEWBORN; CARBON RADIOISOTOPES; FEMALE; FULLERENES; LACTATION; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; METABOLOMICS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; URINE;

RATTUS;

EID: 77952826303     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1503     Document Type: Article

References (25)

1. Alargova RG, Deguchi S, Tsujii K. 2001. Stable colloidal dispersions of fullerenes in polar organic solvents. J. Am. Chem. Soc. 123(43): 10460-10467. (Pubitemid 33015691)
2. Bosman SJ, Nieto SP, Patton WC, Jacobson JD, Corselli JU, Chan PJ. 2005. Development of mammalian embryos exposed to mixed-size nanoparticles. Clin. Exp. Obstet. Gynecol. 32(4): 222-2224.
3. Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. 1997. Physiological parameters values for physiologically based pharmacokinetic models. Toxicol. Indust. Health. 13(4): 407-484. (Pubitemid 27314117)
4. 60. Bioorg. Chem. 24: 376-385.
5. Cho M, Cho WS, Choi M, Kim SJ, Han BS, Kim SH, Kim HO, Sheen YY, Jeong J. 2009. The impact of size of tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol. Lett. 189(3): 177-183.
6. Deguchi S, Alargova RG, Tsujii K. 2001. Stable dispersions of fullerenes, C60 and C70, in water. preparation and characterization. Langmuir 17(19): 6013-6017. (Pubitemid 35330766)
7. Emond C, Birnbaum LS, DeVito MJ. 2004. Physiologically based pharma-cokinetic model for developmental exposures to TCDD in the rat. Toxicol. Sci. 80(1): 115-133
8. Hammarlund-Udenaes M, Fridén M, Syvänen S, Gupta A. 2008. On the rate and extent of drug delivery to the brain. Pharm. Res. 25(8): 1737-1750.
9. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. 1989. Non-transferrin-bound iron in plasma or serum from patients with idiopathic homochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J. Biol. Chem. 1989. 15: 264(8) 4417-4422.
10. Kratschmer W, Lamb L D, Fostiropoulos K, Huffman, D R. 1990. Solid C60: a new form of carbon. Nature 347: 354-358.
11. Lee HB, and Blaufox MD. 1985. Blood volume in the rat. J. Nucl. Med. 25: 72-76.
12. Leiderman J, Wiznitzer A, Glezerman M, Feldman B, Levy J, Sharoni Y.1993. Estrogen and progesterone receptors in the uterine artery of rats during and after pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 51(1): 35-40.
13. Lyon DY, Adams LK, Falkner JC, Alvarezt PJ. 2006. Antibacterial activity of fullerene water suspensions: effects of preparation method and particle size. Environ. Sci. Technol. 40(14): 4360-4366.
14. Moghimi SM. 1995. Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents. Adv. Drug Deliv. Rev. 17(1): 1035-1115
15. Moussa F, Pressac M, Genin E, Roux S, Trivin F, Rassat A, Céolin R, Szwarc H. 1997. Quantitative analysis of C60 fullerene in blood and tissues by high-performance liquid chromatography with photodiode-array and mass spectrometric detection. J. Chromatogr. B. Biomed. Sci. Applic. 696(1): 153-159.
16. Rinderknecht A, Oberdorster G, De Mesy B K, Gelein R, Elder A, Brewer K, Miller R. 2009. Nanoparticles and the maternal fetal barrier: do they cross? Birth Defects Res. 85(5): 401.
17. 60, its suspension in water, and its uptake by human keratinocytes J. Am. Chem. Soc. 116: 4517-4518.
18. St-Louis J, Sicotte B, Beasejour A, Brouchu, M. 2006. Remodeling and angiotensin II responses of the uterine arcuate arteries of pregnant rats are altered by low and high sodium intake. Reproduction 131: 331-339.
19. Sumner S, Snyder R, Burgess J, Myers C, Tyl R, Sloan C, Fennell T. 2009. Metabolomics in the assessment of chemical-induced reproductive and developmental outcomes using non-invasive biological fluids: application to the study of butyl-benzyl phthalate. J. Appl.Toxicol. 29(8): 703-714. DOI: 10.1002/JAT.1462.
20. 14C]C60 on the chondrogenesis in rat embryonic limb bud cell culture system. Biochem. Biophys. Res. Commun. 206(3): 885-894.
21. Tsuchiya T, Oguri I, Yamakoshi YN, Miyata N. 1996. Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo. FEBS Lett. 393: 139-145. (Pubitemid 26298248)
22. Weiss BM, Hess OM. 2000. Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur. Heart J. 21, 104-115.
23. Weljie AM, Newton J, Mercier PM, Carlson E, Slupsky CM. 2006. Targeted profiling: quantitative analysis of 1H-NMR metabolomics data. Anal. Chem. 78(13): 4430-4442.
24. 14C labeling, absorption, distribution, excretion and acute toxicity. Chem. Biol. 2: 385-389.
25. Yamakoshi NY, Yagami T, Fukuhara K, Sueyoshia S, Miyata N. 1994. Solubilization of fullerenes into water with polyvinylpyrrolidone applicable to biological tests. J. Chem. Soc., Chem. Commun. 517-518.